sponsored links

UK’s NICE backs Roche drug as maintenance therapy (Reuters)

Sponsored Links

Reuters – Roche’s cancer drug MabThera has been recommended for use on Britain’s state health service as a maintenance therapy for patients with follicular non-Hodgkin’s lymphoma, expanding the market for the medicine.

View full post on Yahoo! News: Health News


Sponsored Links
You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

AddThis Social Bookmark Button

Leave a Reply

You must be logged in to post a comment.